SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Sahar SaeedSteven J DrewsChantale PambrunQi-Long YiLori OsmondSheila F O'BrienPublished in: Transfusion (2021)
Worldwide, blood services have leveraged their operational capacity to inform public health. While >99% of Canadians did not show humoral evidence of past infection, we found regional variability and disparities by ethnicity. Seroprevalence studies will continue to play a pivotal role in evaluating public health policies by identifying trends and monitor disparities.